SenesTech, Inc. (SNES) AI Stock Analysis

SenesTech, Inc., based in Phoenix, Arizona, pioneers technology aimed at managing animal pest populations through fertility control methods. Established in 2004, the company focuses on fertility control rather than traditional extermination techniques to provide sustainable pest management solutions. Its flagship product, ContraPest, is a specialized liquid bait designed to reduce the reproduction rates of both male and female rats, curbing their population growth and minimizing ecosystem impacts. The company conducts research and development to expand its proprietary technology beyond rats, aiming to address pest control challenges across urban and agricultural environments.

SenesTech expanded annual revenue from $576,000 in FY2021 to $2.2M in FY2025, producing a 5-year revenue CAGR of 53.8% from FY2020 to FY2025. Annual revenue growth was 123.3% in FY2021, 76.9% in FY2022, 17.1% in FY2023, 55.7% in FY2024, and 19.6% in FY2025. Gross margin improved from 38.2% in FY2021 to 62.5% in FY2025. However, operating losses persisted, with an operating margin of -292.9% and net income of -$6.4M in FY2025. In the latest quarter ended June 30, 2026, quarterly revenue grew 23.2% year-over-year, while trailing twelve-month revenue reached $2.4M alongside a profit margin of -294.7% and an eps of -$1.22.

As of June 30, 2026, SenesTech held $5.1M in cash and short-term investments against total debt of $2.6M, leaving net cash of $2.5M. Total assets stood at $9.4M, with shareholders' equity of $6.1M, a debt-to-equity ratio of 0.43, and a current ratio of 6.78. Free cash flow was -$5.9M in FY2025 on operating cash flow of -$5.8M and capital expenditures of $138,000. Over five years, the company's share count increased 103888.2%.

At a last close of $0.65 on October 16, 2026, SenesTech had a market cap of $3.4M and an enterprise value of $1.6M. The stock traded at a forward P/E of 3.4x, below the median of 13.4x for its US-listed Basic Materials peers. Its price-to-sales was 1.4x versus the peer median of 1.8x, and EV to EBITDA stood at 0.1x compared to the peer median of 10.5x. Over the past year, SNES fell 83.0%, while the S&P 500 (SPY) returned 16.8%. Over five years, SNES declined 100.0% against an 83.0% gain for the S&P 500.

Wall Street coverage consists of 1 Strong Buy rating, 0 Buy, 0 Hold, 0 Sell, and 0 Strong Sell ratings. The mean price target is $6.75, representing 943.3% upside from the last close of $0.65. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $2.9M and an EPS of -$1.39. For the next fiscal year, 2 analysts project revenue of $4.5M and an EPS of -$1.10. SenesTech beat EPS estimates in 2 of the last 4 quarters, with its next earnings date scheduled for November 9, 2026.

This page is an AI-written research summary of SenesTech, Inc. (SNES). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: SNES income statement, SNES balance sheet, SNES key metrics, SNES analyst forecast, SNES chart. See the SNES stock overview for the latest quote and news.